Difference between revisions of "Chikuma S, et al. Cancer Sci. (2017) cited as Ref 311 in DOI: 10.1038/s41392-020-0110-5 (Q9574)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 108, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: Fourth Author string (P152): Yoshimura A, #quickstatements; #temporary_batch_1590155310798) |
||
(2 intermediate revisions by the same user not shown) | |||
Property / title | |||
+ | Suppressors of cytokine signaling: potential immune checkpoint molecules for cancer immunotherapy (English) | ||
Property / title: Suppressors of cytokine signaling: potential immune checkpoint molecules for cancer immunotherapy (English) / rank | |||
+ | Normal rank | ||
Property / Page(s) | |||
+ | 574-580 | ||
Property / Page(s): 574-580 / rank | |||
+ | Normal rank | ||
Property / Fourth Author string | |||
+ | Yoshimura A | ||
Property / Fourth Author string: Yoshimura A / rank | |||
+ | Normal rank |
Latest revision as of 13:49, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Chikuma S, et al. Cancer Sci. (2017) cited as Ref 311 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Chikuma S
0 references
Kanamori M
0 references
Mise-Omata S
0 references
2017
0 references
Cancer Sci.
0 references
108
0 references
Suppressors of cytokine signaling: potential immune checkpoint molecules for cancer immunotherapy (English)
0 references
574-580
0 references
Yoshimura A
0 references